Suppr超能文献

Han系SPRD多囊肾大鼠肾衰竭的进展

Progression of renal failure in the Han: SPRD polycystic kidney rat.

作者信息

Zeier M, Pohlmeyer G, Deerberg F, Schönherr R, Ritz E

机构信息

Department Internal Medicine, Ruperto Carola University Heidelberg, Germany.

出版信息

Nephrol Dial Transplant. 1994;9(12):1734-9.

PMID:7708256
Abstract

The Han: SPRD Pkd rat mutant is an autosomal dominant rat model with incomplete penetration of polycystic renal transformation. Progressive renal failure occurs in heterozygous male animals. The mechanisms of progression have not been elucidated. To identify some pathogenetic factors involved we subjected male SPRD Pkd rats (and their non-affected littermates as controls) to uninephrectomy (UNX), castration or enalapril treatment. To assess progression S-urea at age 150 days was chosen as endpoint. (i) In uninephrectomized male Han: SPRD Pkd (n = 12 animals per group) S-urea at age 150 days was consistently above 300 mg/dl, while it was 245 mg/dl (191-290) in control Han: SPRD Pkd. (ii) In castrated male Han: SPRD median S urea at 150 days was 100 mg/dl (69-211) compared to sham-operated male Han: SPRD controls (245; 191-290). Castration did not, however, prevent accelerated progression after uninephrectomy. (iii) Enalapril (50 mg/l) in the drinking fluid did not significantly lower median systolic blood pressure (by plethysmography) in animals on 0.2% sodium diet (at 185 days 160 mmHg; 140-170 versus 170; 140-195 in non-enalapril controls), although circulating ACE was significantly inhibited (17 U; 11-33 versus 89; 52-108 in controls). S-urea at age 185 days was not significantly different in the 2 groups. In conclusion, the Han: SPRD Pkd model differs from human ADPKD to some extent. Uninephrectomy accelerates renal failure in the rat, but not in humans. On the other hand, in contrast to human ADPKD the renin system is suppressed in the rat model and ACE inhibition does not affect the course of renal failure.

摘要

Han:SPRD Pkd大鼠突变体是一种常染色体显性大鼠模型,多囊肾转化的外显率不完全。杂合子雄性动物会发生进行性肾衰竭。其进展机制尚未阐明。为了确定一些相关的致病因素,我们对雄性SPRD Pkd大鼠(及其未受影响的同窝仔鼠作为对照)进行了单侧肾切除术(UNX)、去势或依那普利治疗。为了评估进展情况,选择150日龄时的血清尿素(S-urea)作为终点指标。(i)在接受单侧肾切除术的雄性Han:SPRD Pkd大鼠(每组12只动物)中,150日龄时的S-urea始终高于300mg/dl,而对照Han:SPRD Pkd大鼠的该值为245mg/dl(191 - 290)。(ii)在去势的雄性Han:SPRD大鼠中,150日龄时的S-urea中位数为100mg/dl(69 - 211),而假手术的雄性Han:SPRD对照大鼠为245mg/dl(191 - 290)。然而,去势并不能预防单侧肾切除术后的加速进展。(iii)在饮用含0.2%钠饮食的动物中,饮水中的依那普利(50mg/l)并未显著降低平均收缩压(通过体积描记法)(185日龄时为160mmHg;140 - 170,而非依那普利对照组为170mmHg;140 - 195),尽管循环中的血管紧张素转换酶(ACE)被显著抑制(17U;11 - 33,对照组为89U;52 - 108)。两组在185日龄时的S-urea没有显著差异。总之,Han:SPRD Pkd模型在一定程度上不同于人类常染色体显性多囊肾病(ADPKD)。单侧肾切除术会加速大鼠的肾衰竭,但在人类中不会。另一方面,与人类ADPKD相反,大鼠模型中的肾素系统受到抑制,ACE抑制并不影响肾衰竭的进程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验